Fairmount Healthcare Fund II GP LLC — SEC Form 4 filings
SEC reporting owner CIK 1830382. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-13.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-24 to 2026-05-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 3,707,205 shares, $69,999,970 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 1,600,000 shares @ $18.75 ($30,000,000) in Viridian Therapeutics, Inc.\DE, filed 2024-09-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | Director, 10% owner | 6 | 4 legs · 3,707,205 sh · $69,999,970 | — | 8 |
Form 4 filings — Fairmount Healthcare Fund II GP LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-13 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P. | Purchase (P): 1,176,470 @ $17 | EDGAR |
| 2025-10-27 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P. | Purchase (P): 454,545 @ $22 | EDGAR |
| 2025-06-11 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P. | Option exercise (M): 1,600 @ $7.80 · Option exercise (M): 12,500 @ $12.31 · Option exercise (M): 1,600 (derivative) @ $0 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P. | Purchase (P): 1,600,000 @ $18.75 | EDGAR |
| 2024-04-01 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund GP LLC, Fairmount Healthcare Fund L.P., Fairmount Healthcare Fund II L.P. | Other (J): 5,859 · Other (J): 5,859 · Other (J): 21,999 (derivative) @ $0 · Other (J): 21,999 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) jointly with Fairmount Funds Management LLC, Fairmount Healthcare Fund GP LLC, Fairmount Healthcare Fund L.P., Fairmount Healthcare Fund II L.P. | Purchase (P): 476,190 @ $21 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830382 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →